Invest now
Shalby share price
Balanced risk
- ₹164.00(-1.88%)July 17, 2026 15:29:32 PM IST
- NSE
- BSE
- Vol : 52.96 K (NSE + BSE)Last 20 day avg : 82.57 K
Shalby is trading -1.88% lower at Rs 164.00 as compared to its last closing price. Shalby has been trading in the price range of 166.45 & 162.95. Shalby has given -18.36% in this year & -1.82% in the last 5 days. Shalby has TTM P/E ratio 36.45 as compared to the sector P/E of 31.66.There are 1 analysts who have initiated coverage on Shalby. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 18.32 Crores in its last quarter.Listed peers of Shalby include Apollo Hospitals Enterprise (-0.80%), Max Healthcare Institute (-0.75%), Fortis Healthcare (-0.59%).The Mutual Fund holding in Shalby was at 0.01% in 30 Jun 2026. The MF holding has - from the last quarter. The FII holding in Shalby was at 4.47% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 17 Jul 2026, 07:25 PM IST
- BetaMedium volatility1.01Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.59The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-2.69The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Shalby News
Shalby Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 8,815.40 | -0.80 | 1,26,611.11 | 65.38 | 13.48 | - | - |
| Max Healthcare Institute | 1,090.45 | -0.75 | 1,06,130.60 | 72.01 | 9.94 | - | - |
| Fortis Healthcare | 957.75 | -0.59 | 72,235.36 | 68.65 | 7.35 | - | - |
| Aster DM Healthcare | 817.60 | 0.76 | 42,115.44 | 101.57 | 9.17 | - | - |
| Narayana Hrudayalaya | 2,029.05 | -0.07 | 41,304.46 | 48.19 | 9.11 | - | - |
Mutual Fund Ownership
View allShalby Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-27 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
About the company Shalby
- IndustryHealthcare Facilities
- ISININE597J01018
- BSE Code540797
- NSE CodeSHALBY
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company is engaged in the business of setting up and managing hospitals and medical diagnostic services. The Company’s Hospitals divisions include Multispecialty, Shalby Orthopedics Centre of Excellence (SOCE), Shalby Homecare, and Shalby Academy. Its Slaney Healthcare (Surgical & Pharma Products) divisions include Hosply (Hospital Supplies). Its Shalby MedTech divisions include Shalby Advanced Technologies Inc., USA (SAT), and Shalby Global Technologies PTE Ltd, Singapore (SGT). The Company offers a range of specialties, which include Bone and Joint, Cardiac Sciences, Cosmetic and Aesthetic, Dental Cosmetic and Implantology, Dermatology, Emergency Medicine, ENT Surgery, Gastro Sciences, General Medicine, General Surgery, Infertility and IVF, Intensive and Critical Care, Kidney Sciences, Liver Transplantation, Maxillofacial Surgery, Obstetrics and Gynaecology, Onco Sciences, and more.
Shalby Share Price FAQs
Shalby is trading at 164.00 as on Fri Jul 17 2026 09:59:32. This is -1.88% lower as compared to its previous closing price of 167.15.
The market capitalization of Shalby is 1780.49 Cr as on Fri Jul 17 2026 09:59:32.
The average broker rating on Shalby is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Shalby is 274.50 whereas the 52 wk low is 125.70
Shalby can be analyzed on the following key metrics -
- TTM P/E: 36.45
- Sector P/E: 31.66
- Dividend Yield: 0.00%
- D/E ratio: 0.59
Shalby reported a net profit of 37.39 Cr in 2026.
The Mutual Fund Shareholding was 0.01% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Shalby QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.